Mirna expression in bladder cancer and their potential role in clinical practice

Ana Blanca, Liang Cheng, Rodolfo Montironi, Holger Moch, Francesco Massari, Michelangelo Fiorentino, Maria Rosaria Raspollini, Marina Scarpelli, Antonio Lopez-Beltran

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Background: To date more than 3000 miRNA sequences have been described in humans and registered at miRBase since their discovery. However, the functions of only a few of these miRNAs have been experimentally determined using deep sequencing technology. Aberrant miRNA expression has been associated with differentiation, invasion and metastasis in several cancers. In this context, recent reports have suggested that miRNAs play important roles in the regulation of target genes by binding to complementary regions of messenger transcripts to repress their translation or regulate degradation. In addition, the expression profiles of certain miRNAs can function biologically as oncogenes and tumor suppressor genes. Method: In this review, we summarize the relationship between miRNAs expression and Bladder Cancer (BC). A comprehensive review of the literature has shown a differential expression between malignant and normal tissues, and that miRNAs could be the driving molecules of the BC progression. Similarly, the expression levels of miRNAs in urine and blood samples of BC patients have been demonstrated to be different from healthy people, a finding that might have diagnostic value. Conclusion: In conclusion, the understanding of miRNAs mechanisms and cell distribution provides new opportunities for diagnosis, prognostic, disease monitoring and personalized therapy of BC patients.

Original languageEnglish (US)
Pages (from-to)712-722
Number of pages11
JournalCurrent Drug Metabolism
Volume18
Issue number8
DOIs
StatePublished - Jan 1 2017

Fingerprint

MicroRNAs
Urinary Bladder Neoplasms
Genes
High-Throughput Nucleotide Sequencing
Tumor Suppressor Genes
Oncogenes
Tumors
Blood
Urine
Tissue
Neoplasm Metastasis
Technology
Degradation
Molecules
Monitoring

Keywords

  • Biomarker
  • Bladder cancer
  • Diagnosis
  • Disease monitoring
  • MIRNA
  • Prognosis

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Biochemistry

Cite this

Blanca, A., Cheng, L., Montironi, R., Moch, H., Massari, F., Fiorentino, M., ... Lopez-Beltran, A. (2017). Mirna expression in bladder cancer and their potential role in clinical practice. Current Drug Metabolism, 18(8), 712-722. https://doi.org/10.2174/1389200218666170518164507

Mirna expression in bladder cancer and their potential role in clinical practice. / Blanca, Ana; Cheng, Liang; Montironi, Rodolfo; Moch, Holger; Massari, Francesco; Fiorentino, Michelangelo; Raspollini, Maria Rosaria; Scarpelli, Marina; Lopez-Beltran, Antonio.

In: Current Drug Metabolism, Vol. 18, No. 8, 01.01.2017, p. 712-722.

Research output: Contribution to journalReview article

Blanca, A, Cheng, L, Montironi, R, Moch, H, Massari, F, Fiorentino, M, Raspollini, MR, Scarpelli, M & Lopez-Beltran, A 2017, 'Mirna expression in bladder cancer and their potential role in clinical practice', Current Drug Metabolism, vol. 18, no. 8, pp. 712-722. https://doi.org/10.2174/1389200218666170518164507
Blanca, Ana ; Cheng, Liang ; Montironi, Rodolfo ; Moch, Holger ; Massari, Francesco ; Fiorentino, Michelangelo ; Raspollini, Maria Rosaria ; Scarpelli, Marina ; Lopez-Beltran, Antonio. / Mirna expression in bladder cancer and their potential role in clinical practice. In: Current Drug Metabolism. 2017 ; Vol. 18, No. 8. pp. 712-722.
@article{fd2e68a95a984b668164abfdde8e0982,
title = "Mirna expression in bladder cancer and their potential role in clinical practice",
abstract = "Background: To date more than 3000 miRNA sequences have been described in humans and registered at miRBase since their discovery. However, the functions of only a few of these miRNAs have been experimentally determined using deep sequencing technology. Aberrant miRNA expression has been associated with differentiation, invasion and metastasis in several cancers. In this context, recent reports have suggested that miRNAs play important roles in the regulation of target genes by binding to complementary regions of messenger transcripts to repress their translation or regulate degradation. In addition, the expression profiles of certain miRNAs can function biologically as oncogenes and tumor suppressor genes. Method: In this review, we summarize the relationship between miRNAs expression and Bladder Cancer (BC). A comprehensive review of the literature has shown a differential expression between malignant and normal tissues, and that miRNAs could be the driving molecules of the BC progression. Similarly, the expression levels of miRNAs in urine and blood samples of BC patients have been demonstrated to be different from healthy people, a finding that might have diagnostic value. Conclusion: In conclusion, the understanding of miRNAs mechanisms and cell distribution provides new opportunities for diagnosis, prognostic, disease monitoring and personalized therapy of BC patients.",
keywords = "Biomarker, Bladder cancer, Diagnosis, Disease monitoring, MIRNA, Prognosis",
author = "Ana Blanca and Liang Cheng and Rodolfo Montironi and Holger Moch and Francesco Massari and Michelangelo Fiorentino and Raspollini, {Maria Rosaria} and Marina Scarpelli and Antonio Lopez-Beltran",
year = "2017",
month = "1",
day = "1",
doi = "10.2174/1389200218666170518164507",
language = "English (US)",
volume = "18",
pages = "712--722",
journal = "Current Drug Metabolism",
issn = "1389-2002",
publisher = "Bentham Science Publishers B.V.",
number = "8",

}

TY - JOUR

T1 - Mirna expression in bladder cancer and their potential role in clinical practice

AU - Blanca, Ana

AU - Cheng, Liang

AU - Montironi, Rodolfo

AU - Moch, Holger

AU - Massari, Francesco

AU - Fiorentino, Michelangelo

AU - Raspollini, Maria Rosaria

AU - Scarpelli, Marina

AU - Lopez-Beltran, Antonio

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: To date more than 3000 miRNA sequences have been described in humans and registered at miRBase since their discovery. However, the functions of only a few of these miRNAs have been experimentally determined using deep sequencing technology. Aberrant miRNA expression has been associated with differentiation, invasion and metastasis in several cancers. In this context, recent reports have suggested that miRNAs play important roles in the regulation of target genes by binding to complementary regions of messenger transcripts to repress their translation or regulate degradation. In addition, the expression profiles of certain miRNAs can function biologically as oncogenes and tumor suppressor genes. Method: In this review, we summarize the relationship between miRNAs expression and Bladder Cancer (BC). A comprehensive review of the literature has shown a differential expression between malignant and normal tissues, and that miRNAs could be the driving molecules of the BC progression. Similarly, the expression levels of miRNAs in urine and blood samples of BC patients have been demonstrated to be different from healthy people, a finding that might have diagnostic value. Conclusion: In conclusion, the understanding of miRNAs mechanisms and cell distribution provides new opportunities for diagnosis, prognostic, disease monitoring and personalized therapy of BC patients.

AB - Background: To date more than 3000 miRNA sequences have been described in humans and registered at miRBase since their discovery. However, the functions of only a few of these miRNAs have been experimentally determined using deep sequencing technology. Aberrant miRNA expression has been associated with differentiation, invasion and metastasis in several cancers. In this context, recent reports have suggested that miRNAs play important roles in the regulation of target genes by binding to complementary regions of messenger transcripts to repress their translation or regulate degradation. In addition, the expression profiles of certain miRNAs can function biologically as oncogenes and tumor suppressor genes. Method: In this review, we summarize the relationship between miRNAs expression and Bladder Cancer (BC). A comprehensive review of the literature has shown a differential expression between malignant and normal tissues, and that miRNAs could be the driving molecules of the BC progression. Similarly, the expression levels of miRNAs in urine and blood samples of BC patients have been demonstrated to be different from healthy people, a finding that might have diagnostic value. Conclusion: In conclusion, the understanding of miRNAs mechanisms and cell distribution provides new opportunities for diagnosis, prognostic, disease monitoring and personalized therapy of BC patients.

KW - Biomarker

KW - Bladder cancer

KW - Diagnosis

KW - Disease monitoring

KW - MIRNA

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=85038626021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038626021&partnerID=8YFLogxK

U2 - 10.2174/1389200218666170518164507

DO - 10.2174/1389200218666170518164507

M3 - Review article

VL - 18

SP - 712

EP - 722

JO - Current Drug Metabolism

JF - Current Drug Metabolism

SN - 1389-2002

IS - 8

ER -